C&R Research provides comprehensive strategies and consulting services for global clinical trial development, through a number of professionals with extensive experience in multinational clinical trials in each country.
Global Regulatory Affairs Strategy
Global Feasibility Strategy
Market Access & Entrance Survey
CMC (Chemistry, Manufacturing and Controls)
CTD (Common Technical Document)
CDISC (Clinical Data Interchange Standards Consortium)
Global RA Expertise
C&R Research is able to manage real-time web based reporting from RA teams in the U.S., China, ASEAN countries, Japan and Taiwan. Then, Korea’s global RA consultants offer a range of database options and consulting to help clients establish regulatory strategies to suit multinational trials.
Feasibility & Budgeting
Through closer collaboration with its branch offices overseas, a global network of CROs and government-led clinical organizations, C&R Research acquires relevant data from each country to provide a streamlined global feasibility strategy per indication in each clinical development phase and a suitable study budget within a short period of time.
Global Market Survey
Based on the reports obtained from its branch offices overseas and partners, C&R Research selects a list of strategic countries suitable for multinational clinical trials and offer support in client’s development process in each country.
C&R Research provides regulatory compliance consulting on CMC, CTD and CDISC that are required in data submission for the U.S. Food and Drug Administration and European Medicines Agency.
For more information